Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LP 118

Next Previous
X
Search
Drug Profile

LP 118

Alternative Names: LP-118

Latest Information Update: 16 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Newave Pharmaceuticals
  • Developer Guangzhou Lupeng Pharmaceutical; Newave Pharmaceuticals
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Bcl-X protein inhibitors; Proto-oncogene protein c-bcl-2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Acute myeloid leukaemia; B-cell lymphoma; Chronic lymphocytic leukaemia; Haematological malignancies; Multiple myeloma; Precursor cell lymphoblastic leukaemia-lymphoma; Small cell lung cancer; Solid tumours

Most Recent Events

  • 05 Apr 2024 Pharmacodynamics and adverse event data from a preclinical trial in Small cell lung cancer presented at the 115th Annual Meeting of the American Association for Cancer Research (AACR-2024)
  • 09 Dec 2023 Pharmacodynamics data from the preclinical trial in Cancer presented at the 65th American Society of Hematology Annual Meeting and Exposition 2023 (ASH-Hem 2023)
  • 13 Jan 2023 pharmacodynamics data from a preclinical study in Acute myeloid leukemia (AML) presented at the 64th American Society of Hematology Annual Meeting and Exposition (ASH-2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top